drugset

drugset / Trial / NCT05571813

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

NCT05571813 ↗

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical

RandomizedCrossoverOpen-labelTreatment

Summary

Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects

Timeline

Start: 2022-11-02
Primary completion: 2022-12-04
Completion: 2022-12-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CKD-341	Unknown	—	—

Indications